ST Germain D J Co. Inc. Grows Stock Holdings in Danaher Corporation $DHR

ST Germain D J Co. Inc. grew its position in Danaher Corporation (NYSE:DHR) by 147.6% during the third quarter, Holdings Channel reports. The institutional investor owned 94,853 shares of the conglomerate’s stock after acquiring an additional 56,547 shares during the quarter. ST Germain D J Co. Inc.’s holdings in Danaher were worth $18,806,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. WFA of San Diego LLC purchased a new position in Danaher in the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the second quarter valued at approximately $27,000. Red Tortoise LLC lifted its stake in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the period. Heartwood Wealth Advisors LLC acquired a new position in Danaher during the third quarter worth $37,000. Finally, Ramirez Asset Management Inc. acquired a new position in shares of Danaher during the 2nd quarter worth about $40,000. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. This trade represents a 59.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director directly owned 20,762 shares in the company, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 30,248 shares of company stock valued at $6,609,663. 11.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently commented on DHR shares. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Bank of America cut their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Robert W. Baird set a $247.00 target price on shares of Danaher in a report on Wednesday, October 22nd. Rothschild Redb downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Twenty equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $247.21.

Danaher Price Performance

DHR stock opened at $224.72 on Wednesday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The firm has a market capitalization of $158.73 billion, a P/E ratio of 46.33, a P/E/G ratio of 4.44 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The business’s 50-day moving average is $219.17 and its two-hundred day moving average is $206.42.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the company earned $1.71 earnings per share. The firm’s revenue was up 4.4% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.